Insights

Global Expansion Relypsa, now Vifor Pharma, has successfully integrated and rebranded to expand its reach as a global leader in iron deficiency, nephrology, and cardio-renal therapies. This transition presents an opportunity to engage new markets and broaden the scope of potential sales.

Innovative Product Vifor Pharma's development of Veltassa® (patiromer) for oral suspension showcases its innovative approach rooted in polymer science. This unique product offering can be leveraged to attract healthcare providers looking for advanced treatment solutions, creating a sales advantage.

Tech-Savvy Operations With a tech stack including SAS, Python, and Cloudflare, Vifor Pharma demonstrates a commitment to leveraging technology for efficiency and excellence. Positioning its advanced tech capabilities in sales pitches can appeal to clients seeking partners with cutting-edge solutions.

Financial Stability Having secured $150M in funding, Vifor Pharma exhibits financial stability and growth potential. This positive financial standing can instill confidence in potential buyers, making it an opportune moment to present sales propositions for partnerships or product acquisitions.

Competitive Analysis Analyzing key competitors like Fresenius Medical Care and DaVita in the renal care industry can provide valuable insights for positioning Vifor Pharma strategically. By understanding market dynamics and competitor positioning, sales strategies can be tailored to capitalize on gaps and strengths in the market.

Relypsa Tech Stack

Relypsa uses 8 technology products and services including SAS, Cloudflare, Responsa, and more. Explore Relypsa's tech stack below.

  • SAS
    Business Intelligence
  • Cloudflare
    Content Management System
  • Responsa
    Customer Service
  • Exhibit
    Javascript Graphics
  • Informa
    Miscellaneous
  • Microsoft Windows Server
    Operating Systems
  • Python
    Programming Languages
  • Concur
    Travel And Expense Management

Media & News

Relypsa's Email Address Formats

Relypsa uses at least 2 format(s):
Relypsa Email FormatsExamplePercentage
FLast@relypsa.comJDoe@relypsa.com
88%
Last@relypsa.comDoe@relypsa.com
6%
FiLast@relypsa.comJoDoe@relypsa.com
2%
First.Last@relypsa.comJohn.Doe@relypsa.com
1%
LF@relypsa.comDJ@relypsa.com
1%
LFirst@relypsa.comDJohn@relypsa.com
1%
First@relypsa.comJohn@relypsa.com
1%
First.Last@viforpharma.comJohn.Doe@viforpharma.com
91%
FLast@viforpharma.comJDoe@viforpharma.com
4%
Last.First@viforpharma.comDoe.John@viforpharma.com
3%
First.Middle@viforpharma.comJohn.Michael@viforpharma.com
2%

Frequently Asked Questions

Where is Relypsa's headquarters located?

Minus sign iconPlus sign icon
Relypsa's main headquarters is located at 100 Cardinal Way Redwood City, CA 94063 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Relypsa's phone number?

Minus sign iconPlus sign icon
You can contact Relypsa's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Relypsa's stock symbol?

Minus sign iconPlus sign icon
Relypsa is a publicly traded company; the company's stock symbol is RLYP.

What is Relypsa's official website and social media links?

Minus sign iconPlus sign icon
Relypsa's official website is viforpharma.com and has social profiles on LinkedIn.

What is Relypsa's SIC code NAICS code?

Minus sign iconPlus sign icon
Relypsa's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Relypsa have currently?

Minus sign iconPlus sign icon
As of August 2023, Relypsa has approximately 201 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Dev. Officer And Sr. Vp: C. L.Vice President Clinical Development: M. M.Vice President Regulatory Affairs: Z. R.. Explore Relypsa's employee directory with LeadIQ.

What industry does Relypsa belong to?

Minus sign iconPlus sign icon
Relypsa operates in the Biotechnology Research industry.

What technology does Relypsa use?

Minus sign iconPlus sign icon
Relypsa's tech stack includes SASCloudflareResponsaExhibitInformaMicrosoft Windows ServerPythonConcur.

What is Relypsa's email format?

Minus sign iconPlus sign icon
Relypsa's email format typically follows the pattern of . Find more Relypsa email formats with LeadIQ.

How much funding has Relypsa raised to date?

Minus sign iconPlus sign icon
As of August 2023, Relypsa has raised $150M in funding. The last funding round occurred on May 03, 2016 for $150M.

When was Relypsa founded?

Minus sign iconPlus sign icon
Relypsa was founded in 2007.
Relypsa

Relypsa

Biotechnology ResearchCalifornia, United States201-500 Employees

Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies. 

Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives.  We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science. 

Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones. 

(Our community guidelines: viforpharma.com/linkedin-cg)

Section iconCompany Overview

Headquarters
100 Cardinal Way Redwood City, CA 94063 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RLYP
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $150M

    Relypsa has raised a total of $150M of funding over 10 rounds. Their latest funding round was raised on May 03, 2016 in the amount of $150M.

Section iconFunding & Financials

  • $150M

    Relypsa has raised a total of $150M of funding over 10 rounds. Their latest funding round was raised on May 03, 2016 in the amount of $150M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.